Structure |
Chemical Name |
CAS |
MF |
|
Alogliptin Impurity E |
|
|
|
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni |
120511-92-4 |
C17H19N5 |
|
Acarbose Impurity D |
|
|
|
Acarbose Impurity C |
|
|
|
Aripiprazole-Impurity 17 |
1424857-89-5 |
C16H17Cl4N3 |
|
Apixaban Impurity 42 |
132577-23-2 |
C12H14N2O4 |
|
2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine |
1353428-89-3 |
C13H17NO |
|
Aripiprazole impurity 20 |
|
|
|
Aripiprazole Impurity 47 |
2250242-47-6 |
C27H33Cl2N3O3 |
|
Afatinib impurity 45 |
99281-87-5 |
C5H9NO2 |
|
Afatinib impurity 48 |
|
|
|
Afatinib Impurity 57 |
|
|
|
Afatinib Impurity ODQ |
|
|
|
Afatinib Impurity QJJ |
2323570-72-3 |
C24H27ClFN5O4 |
|
(S)-tert-butyl (1-(3-(2-cyanobenzyl) |
1618644-31-7 |
C23H29N5O4 |
|
Afatinib impurity 82 |
|
|
|
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- |
1642569-42-3 |
C20H17N5O5 |
|
Benzonitrile, 2-[(3,4-dihydro-6-methoxy-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]- |
2514763-78-9 |
C14H13N3O3 |
|
Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate] |
|
C50H60CaN2O10 |
|
2,3‐デヒドロシリビンB |
142796-24-5 |
C25H20O10 |
|
monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C24H28CaNO5 |
|
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
|
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)- |
104146-11-4 |
C29H27N3O5S2 |
|
Anastrozole Impurity 41 |
|
|
|
(2R-TRANS)-ジルチアゼム塩酸塩 |
103532-27-0 |
C22H27ClN2O4S |
|
2-アミノ-5,6-ジクロロ-3,4-ジヒドロキナゾリン |
444904-63-6 |
C8H7Cl2N3 |
|
Anagrelide impurity 4 |
1092352-99-2 |
C10H6Cl3N3O |
|
2'-[(1H-テトラゾール-5-イル)ビフェニル-4-イル]メタノール |
160514-13-6 |
C14H12N4O |
|
9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
1256584-80-1 |
C21H17IN2O |
|
アゴメラチン二量体尿素 |
185421-27-6 |
C27H28N2O3 |
|
Alogliptin iMpurity |
60271-06-9 |
C7H10N2O3 |
|
(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile |
1268836-55-0 |
C31H30N8O4 |
|
AlMotriptan iMpurity |
|
|
|
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetic acid) |
1338800-82-0 |
C17H20N4O2 |
|
Aripiprazole iMpurity 4 |
1424857-63-5 |
C36H42Cl2N4O4 |
|
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
1639970-62-9 |
C22H23NO4 |
|
Alogliptin Impurity B |
865758-98-1 |
C17H19N5O2 |
|
Ofloxacin/Levofloxacin Impurity A |
|
|
|
methyl(E)-4-(methylamino)but-2-enoate |
915788-22-6 |
C6H11NO2 |
|
ethyl 4-dimethylamino-3-hydroxy-butanoate |
90227-57-9 |
C8H17NO3 |
|
(E)-N-(2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl)acetamide |
178677-39-9 |
C15H19NO2 |
|
Aripiprazole Impurity 11 |
|
|
|
(R)-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H25N7O4 |
|
Acarbose Impurity H |
|
|
|
Anastrozole EP Impurity I |
120511-91-3 |
C15H17ClN2 |
|
Afatinib Impurity 74 |
1259015-90-1 |
C7H13NO2 |
|
Afatinib Impurity 78 |
|
|
|
Anastrozole Impurity I |
|
|
|
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
|
7-PACE Impurity 2 |
|
|
|
N2-Methyl Alfuzosin Hydrochloride |
72104-34-8 |
C19H28ClN5O4 |
|
Anastrozole iMpurity A |
|
|
|
Desloratadine IMpurity 3 |
1346600-61-0 |
C19H19ClN2 |
|
EMpagliflozin iMpurity 11 |
|
|
|
アゼチジン-1-スルホンアミド |
654073-32-2 |
C3H8N2O2S |
|
N-DESMETHYLGALANTHAMINE |
41303-74-6 |
C16H19NO3 |
|
Hydroxy Adapalene |
1346599-76-5 |
C28H28O4 |
|
Adefovir iMpurity |
1875153-79-9 |
C15H24N5O6P |
|
tert-butyl 4-cyclohexylpiperazine-1-carboxylate |
1224935-95-8 |
C15H28N2O2 |
|
Avanafil iMpurity 1 |
372117-54-9 |
C18H22ClN5O3 |
|
Avanafil Impurity 9 |
|
|
|
Afatinib Impurity 17 |
1870880-09-3 |
C20H18Cl2FN5O |
|
Abiraterone Impurity 4 |
2118-32-3 |
C23H34O2 |
|
LCZ Impurity |
753421-85-1 |
C20H25NO2 |
|
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
|
C22H23NO4 |
|
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
|
Formoterol EP Impurity E |
1616967-26-0 |
C20H26N2O4 |
|
(Glu3)-Carbetocin (Impurity D) |
|
|
|
Δ3-7-ACT |
|
|
|
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
|
(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1) |
|
|
|
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
|
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
|
Lacosamide Impurity – K |
|
|
|
(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene |
2229745-37-1 |
C40H74O2Si2 |
|
Ofloxacin/Levofloxacin Impurity B |
|
|
|
(2R,4S)-isopropyl5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1- yl)-2-methylpentanoate |
|
C25H29NO4 |
|
Amylmetacresol EP impurity A |
876473-73-3 |
C12H18O |
|
5-methyl-2-(2-methylbutyl)phenol |
|
C12H18O |
|
7-ADCA Impuirty 1 |
|
|
|
7-PACE Impurity 1 |
|
|
|
(R)-Fluvastatin EP Impurity E |
|
|
|
5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridin-2-yl acetate |
1391194-45-8 |
C20H21NO3S |
|
(Gly8-OH)-Carbetocin (Impurity B) |
|
|
|
D-Asn4-Carbetocin (Impurity F) |
|
|
|
5-Chloro AcesulfaMe |
72827-08-8 |
C4H4ClNO4S |
|
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate |
1038924-97-8 |
C24H27NO4 |
|
3'-chloro-3'-deoxythymidine (zidovudine impurity) |
|
|
|
Ofloxacin/Levofloxacin Impurity E |
|
|
|
4-(4-Hydroxy-3-hydroxymethyl-phenoxy)-benzonitrile |
|
C14H11NO3 |
|
monocalciummono(4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5- methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C23H26CaNO5 |
|
(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate |
2216755-67-6 |
C28H37NO5 |
|
EP Impurity Catalog |
|
|
|
2,4,6,3',5'-pentamethoxybiphenyl |
84212-55-5 |
C17H20O5 |
|
(Asp4)-Carbetocin (Impurity G) |
|
|
|
((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane) |
115540-28-8 |
C40H72O2Si2 |
|
(S,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
|
2-(ヒドロキシメチル)オランザピン |
174756-45-7 |
C17H20N4OS |
|
Flomoxef Impurity 2 |
|
|
|
NA |
|
|